NCT03274076 Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) Status COMPLETED Phase PHASE1/PHASE2
NCT03273842 A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03271047 Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation Status COMPLETED Phase PHASE2
NCT03269695 Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. Status TERMINATED Phase PHASE2
NCT03269136 PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT03267836 Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma Status TERMINATED Phase PHASE1
NCT03266705 A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood Status COMPLETED Phase PHASE1
NCT03266588 Open Label Safety Study in Acute Treatment of Migraine Status COMPLETED Phase PHASE2/PHASE3
NCT03262662 EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking Status COMPLETED Phase PHASE3
NCT03260595 A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03260023 Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03258502 A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection Status COMPLETED Phase PHASE2
NCT03258398 A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03258008 Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer Status TERMINATED Phase PHASE2
NCT03250039 Absorption, Metabolism, Excretion and Absolute Bioavailability Status COMPLETED Phase PHASE1
NCT03248882 Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) Status COMPLETED Phase PHASE2
NCT03248141 Understanding Hemophilia A and B Drug Dosage Administration Patterns Status TERMINATED Phase N/A